Trial Profile
Phase II Trial of First Line Docetaxel and Oxaliplatin in Stage IV or Relapsed Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Oxaliplatin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms BELOXAN
- Sponsors Chonnam National University Hospital
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2010 New trial record